Cargando…

Prevalence of DNA of fourteen human polyomaviruses determined in blood donors

BACKGROUND: Human polyomaviruses (HPyVs), like herpesviruses, cause persistent infection in a large part of the population. In immunocompromised and elderly patients, PyVs cause severe diseases such as nephropathy (BK polyomavirus [BKPyV]), progressive multifocal leukoencephalopathy (JC polyomavirus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamminga, Sergio, van der Meijden, Els, de Brouwer, Caroline, Feltkamp, Mariet, Zaaijer, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2019
Materias:	Donor Infectious Disease Testing
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916541/ https://www.ncbi.nlm.nih.gov/pubmed/31633816 http://dx.doi.org/10.1111/trf.15557

Ejemplares similares

Seroprevalence of fourteen human polyomaviruses determined in blood donors
por: Kamminga, Sergio, et al.
Publicado: (2018)

Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay
por: Levin, Andrew E, et al.
Publicado: (2014)

High prevalence of human T‐cell leukemia virus type‐1b genotype among blood donors in Gabon, Central Africa
por: Ramassamy, Jill‐Léa, et al.
Publicado: (2020)

Detection of dengue, chikungunya, and Zika RNA in blood donors from Southeast Asia
por: Stanley, Jean, et al.
Publicado: (2020)

Human T‐lymphotropic virus in Irish blood donors: Impact on future testing strategy
por: Williams, Pádraig, et al.
Publicado: (2022)

Trends and risk factors of SARS‐CoV‐2 infection in asymptomatic blood donors
por: Valenti, Luca, et al.
Publicado: (2021)

Serologic screening of United States blood donors for Babesia microti using an investigational enzyme immunoassay
por: Levin, Andrew E., et al.
Publicado: (2016)

Evidence of likely autochthonous Chagas disease in the southwestern United States: A case series of Trypanosoma cruzi seropositive blood donors
por: Lynn, Mary K., et al.
Publicado: (2022)

Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program
por: Wendel, Silvano, et al.
Publicado: (2020)

Translating genomic exploration of the family Polyomaviridae into confident human polyomavirus detection
por: Kamminga, Sergio, et al.
Publicado: (2021)

Evaluation of a new West Nile virus nucleic acid test for screening of blood donations
por: Stanley, Jean, et al.
Publicado: (2018)

Duplex nucleic acid test for the detection of chikungunya and dengue RNA viruses in blood donations
por: Stramer, Susan L., et al.
Publicado: (2019)

A WHO tool for risk‐based decision making on blood safety interventions
por: Janssen, Mart P., et al.
Publicado: (2020)

Performance profile of an updated safety measure rapid assay for bacteria in platelets
por: Vallejo, Remo P., et al.
Publicado: (2020)

Longitudinal analysis of SARS‐CoV‐2 antibodies in 8000 U.S. first‐time convalescent plasma donations
por: Karbiener, Michael, et al.
Publicado: (2021)

COVID‐19 antibody screening with SARS‐CoV‐2 red cell kodecytes using routine serologic diagnostic platforms
por: Nagappan, Radhika, et al.
Publicado: (2021)

A novel competition ELISA for the rapid quantification of SARS‐CoV‐2 neutralizing antibodies in convalescent plasma
por: Wouters, Elise, et al.
Publicado: (2021)

Evaluation of an improved rapid bacterial assay with untreated and pathogen‐reduced platelets: Detection of Acinetobacter strains
por: LaVerda, David, et al.
Publicado: (2021)

Detection of Babesia RNA and DNA in whole blood samples from US blood donations
por: Stanley, Jean, et al.
Publicado: (2021)

Acquired platelet storage container leaks and contamination with environmental bacteria: A preventable cause of bacterial sepsis
por: Gammon, Richard R., et al.
Publicado: (2021)

Assessment of Liaison XL Murex Chagas diagnostic performance in blood screening for Chagas disease using a reference array of chimeric antigens
por: Santos, Emily F., et al.
Publicado: (2021)

Economic implications of FDA platelet bacterial guidance compliance options: Comparison of single‐step strategies
por: Prioli, Katherine M., et al.
Publicado: (2022)

Serology Identifies LIPyV as a Feline Rather than a Human Polyomavirus
por: Kamminga, Sergio, et al.
Publicado: (2023)

The Human Polyomavirus Middle and Alternative T-Antigens; Thoughts on Roles and Relevance to Cancer
por: van der Meijden, Els, et al.
Publicado: (2018)

Human Polyomavirus 9 Infection in Kidney Transplant Patients
por: van der Meijden, Els, et al.
Publicado: (2014)

Impact of HPyV9 and TSPyV coinfection on the development of BK polyomavirus viremia and associated nephropathy after kidney transplantation
por: van Rijn, Aline L., et al.
Publicado: (2019)

Seroprevalence of Trichodysplasia Spinulosa–associated Polyomavirus
por: van der Meijden, Els, et al.
Publicado: (2011)

BK Polyomavirus-Induced Nephropathy in Native Kidney
por: Munjal, Ripudaman S, et al.
Publicado: (2023)

Discovery of a New Human Polyomavirus Associated with Trichodysplasia Spinulosa in an Immunocompromized Patient
por: van der Meijden, Els, et al.
Publicado: (2010)

Polyomavirus-Associated Trichodysplasia Spinulosa Involves Hyperproliferation, pRB Phosphorylation and Upregulation of p16 and p21
por: Kazem, Siamaque, et al.
Publicado: (2014)

Different Serologic Behavior of MCPyV, TSPyV, HPyV6, HPyV7 and HPyV9 Polyomaviruses Found on the Skin
por: van der Meijden, Els, et al.
Publicado: (2013)

Borrelia burgdorferi sensu lato seroconversion after intravenous immunoglobulin treatment: A cohort study
por: Lucke, Ilse M., et al.
Publicado: (2021)

T cell deficiency precipitates antibody evasion and emergence of neurovirulent polyomavirus
por: Lauver, Matthew D, et al.
Publicado: (2022)

Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies
por: Law, Arjun Datt, et al.
Publicado: (2018)

Assessing the discrimination of the Kidney Donor Risk Index/Kidney Donor Profile Index scores for allograft failure and estimated glomerular filtration rate in Ireland’s National Kidney Transplant Programme
por: Sexton, Donal J, et al.
Publicado: (2019)

Prevalence and determinants of persistent symptoms after infection with SARS-CoV-2: protocol for an observational cohort study (LongCOVID-study)
por: Mutubuki, Elizabeth N, et al.
Publicado: (2022)

The healthy donor effect and survey participation, becoming a donor and donor career
por: Brodersen, Thorsten, et al.
Publicado: (2022)

Donor and non‐donor perspectives on receiving information from routine genomic testing of donor blood
por: Thorpe, Rachel, et al.
Publicado: (2022)

Incorporating apolipoprotein L1 testing into evaluation of potential living kidney donors: a single-centre experience
por: Dick, Jonathan, et al.
Publicado: (2019)

Donor-derived Transmission of Hepatitis A Virus Following Kidney Transplantation: Clinical Course of Two Cases From One Donor
por: Jones, Jefferson M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n6iksdp67qkh87ms7m52r0ntni